Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel
Open Access
- 15 January 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 16, 172-178
- https://doi.org/10.1016/j.omtm.2019.12.018
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphomaBlood, 2018
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaThe New England Journal of Medicine, 2017
- Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive LymphomaMolecular Therapy, 2017
- Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleasesNature Protocols, 2016
- Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantationExperimental Hematology, 2015
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorJournal of Immunotherapy, 2009
- Pois(s)on – It's a Question of Dose…Gene Therapy, 2004
- Real-Time Quantitative Y Chromosome-Specific PCR (QYCS-PCR) for Monitoring Hematopoietic Chimerism after Sex-Mismatched Allogeneic Stem Cell TransplantationJournal of Hematotherapy & Stem Cell Research, 2001
- Digital PCRProceedings of the National Academy of Sciences of the United States of America, 1999
- Quantitation of targets for PCR by use of limiting dilution.1992